Susceptibility of Clinical Mycobacterium tuberculosis Isolates to a Potentially Less Toxic Derivate of Linezolid, PNU-100480

Susceptibility of clinical Mycobacterium tuberculosis isolates to PNU-100480 and linezolid was evaluated by the MGIT 960 system. The isolates had various susceptibilities to isoniazid (INH), rifampin, ethambutol, and streptomycin. The mean MIC for PNU-100480 was 3.2 times lower than that for linezol...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alffenaar, J. W. C., van der Laan, T., Simons, S., van der Werf, T. S., van de Kasteele, P. J., de Neeling, H., van Soolingen, D.
Format:	Artigo
Language:	Inglês
Published:	American Society for Microbiology (ASM) 2011
Subjects:	Susceptibility
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3067097/ https://ncbi.nlm.nih.gov/pubmed/21199931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01297-10
Tags:	Add Tag No Tags, Be the first to tag this record!

Susceptibility of Clinical Mycobacterium tuberculosis Isolates to a Potentially Less Toxic Derivate of Linezolid, PNU-100480

Similar Items